Dr Maged Gharib
MBChi, MSc, MD, FRCP, FRCPath
I have been a Consultant Haematologist since 2005. I have extensive experience in diagnosing and treating various benign and malignant blood disorders including leukaemias, lymphomas and myelomas, and have been doing so since 1998.
I am the clinical lead in thrombosis and anti-coagulation in STHK NHS Trust. I am interested in studying and managing patients' risk of thrombosis, and I am the principal investigator for the first national trial looking at treating cancer induced thrombosis with the new oral anti-coagulant.
My background experience is in internal medicine which I studied from 1991 to 1998. This provides an excellent foundation in analysing patients symptoms and wider horizon in diagnosis and management.
I have published a wide range of research papers, case reports and textbook chapters and I pride myself in my level of clinical and patient care.
Some of the principal treatments carried out by Dr Maged Gharib at Spire include:
Spire Manchester Hospital is only able to provide Covid-19 tests to patients undergoing surgery at our hospital. Covid-19 testing or antibody tests are not available as a standalone service.
British Society for Haematology
European Haematology Association
Royal College of Pathologists
Royal College of Physicians